InSilico Medicine
VerifiedDevelops an AI platform for drug development to treat cancer and age-related diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$1.1b (Public information from Aug 2022)
Yuen Long District New Territories (HQ)
| USD | 2021 | 2022 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 21 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor investor investor | $0.0 | round |
| investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor investor investor | $0.0 | round | |
| N/A | $0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor investor | $0.0 | round | |
| investor investor investor investor investor investor investor | $0.0 Valuation: $0.0 | round | |
* | $35.0m Valuation: $1.1b | Series D | |
| Total Funding | 000k | ||
Related Content
Recent News about InSilico Medicine
EditInvestments by InSilico Medicine
Edit
ACQUISITION by Regent Pacific Sep 2020